- Stocks
- Pharma & Healthcare
- Amwill Health
Amwill Health share price
NSE: AMWILLPharma & HealthcareMedical Distribution
Amwill Health at a glance
With a market capitalisation of ₹89 Cr, it ranks 2733rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Distribution.
Its return on equity was 15.5% in FY25. Promoters held 70.65% of the company as of 31 Mar 2026.
Key numbers
- Market cap
- ₹89 CrRank 2733 on NSE
- Price to book
- 2×FY25
- ROE
- 15.5%FY25
- ROCE
- 17.1%FY25
- Debt to equity
- 0FY25
- Net profit margin
- 26.4%FY25
- Book value / share
- ₹34.60FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Amwill Health financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | ₹18 Cr | ₹28 Cr | ₹30 Cr | ₹44 Cr | ₹41 Cr |
| Operating profit | −₹1 Cr | ₹3 Cr | ₹4 Cr | ₹17 Cr | ₹12 Cr |
| Net profit | −₹1 Cr | ₹3 Cr | ₹3 Cr | ₹13 Cr | ₹11 Cr |
| EPS (₹) | −₹0.64 | ₹1.65 | ₹2.00 | ₹8.01 | ₹6.63 |
| Cash from operations | ₹0 Cr | ₹3 Cr | ₹5 Cr | −₹3 Cr | ₹6 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | −₹1 Cr | ₹1 Cr | ₹5 Cr | ₹17 Cr | ₹69 Cr |
Amwill Health shareholding pattern
| Holder | 10 Feb 2025 | 31 Mar 2025 | 30 Sep 2025 | 31 Mar 2026 |
|---|---|---|---|---|
| Promoters | 70.65% | 70.65% | 70.65% | 70.65% |
| Non-institutions | 24.22% | 28.19% | 28.19% | 29.35% |
Amwill Health vs peers
The listed Pharma & Healthcare companies nearest to Amwill Health by market capitalisation.
Ask anything about Amwill Health
Pivot answers on the live chart with evidence you can check, and tests strategies against AMWILL's own history. Try: “Why has AMWILL moved over the last three months?” · “Backtest a 50-day moving-average crossover on AMWILL over five years” · “Compare AMWILL with CONCORD on margins and valuation”
Frequently asked questions about Amwill Health
What is the market cap of Amwill Health?
Amwill Health's market capitalisation is ₹89 Cr (₹89 Cr) at the 22 Oct 2026 close, ranking 2733rd among the NSE companies Pivot tracks.
What is the ROE and ROCE of Amwill Health?
Return on equity was 15.5% in FY25 and return on capital employed was 17.1% in FY25 (standalone figures).
Is Amwill Health a debt-free company?
Amwill Health is close to debt-free: its debt-to-equity ratio was 0 in FY25.
What is the shareholding pattern of Amwill Health?
As of 31 Mar 2026: promoters 70.65%, non-institutions 29.35%.
Who are Amwill Health's competitors?
The listed Pharma & Healthcare companies closest to Amwill Health by market cap are Concord Drugs, Denis Chem Lab, Fortis Malar, Raaj Medisafe, KHFM HOSPITALIT and Modern Diagnost.
Is Amwill Health a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Amwill Health's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on AMWILL against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with A · all NSE stocks · this page as text